No SC relief for Sterling Biotech on one-time settlement to banks

Richmond, in its application, had sought the extra time to save SBL from impending liquidation saying that if liquidation happens, it “will affect the pharmaceutical industry as 60 per cent of capsules sold in the country are manufactured from gelatin produced by the company which will have devastating disruption during this pandemic”.

The plea contended that several thousand employees would lose their jobs if the liquidation goes through.

In an additional affidavit, the company said that SBL promoters, Nitin Sandesara, Chetankumar Sandesara, Dipti Chetan Sandesara and Hiteshkumar Patel “are facing a frivolous prosecution including under PMLA (Prevention of Money Laundering Act) for alleged default in payment towards the loan accounts.”